BlueCube Bio Becomes Evia Bio™ and Launches New IPSC Cryopreservation Solution to Accelerate Cell & Gene Therapies

BlueCube Bio officially announced a company name transition to Evia Bio™, concurrent with the launch of a significant new cryopreservation technology for use in cell and gene therapies utilizing iPSCs.